Gossamer Bio (GOSS)
Develops inhaled seralutinib for pulmonary arterial hypertension and PH-ILD.
$12.05
vs last close+0.77 (+6.83%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$3.89
Revenue estimate
$10.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.15−$12.80−$0.17−$16.80−$0.21−$0.20−$6.40Pending
Estimate−$13.60−$15.20−$14.40−$15.20−$16.00−$13.60−$9.87−$3.89
Surprise+98.9%+15.8%+98.8%−10.5%+98.7%+98.5%+35.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$9.4M$9.9M$11.5M$13.3M$13.8M$17.0M$9.2MPending
Estimate$6.8M$4.1M$5.4M$6.4M$7.5M$4.7M$3.6M$10.7M
Surprise+37.2%+143.1%+112.4%+108.3%+83.4%+263.2%+154.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.00 | — | — |
| Sep 2027 | −$4.15 | — | — |
| Jun 2027 | −$4.66 | — | — |
| Mar 2027 | −$0.07 | — | — |
| Dec 2026 | −$3.69 | — | — |
| Nov 2026 | −$3.89 | — | — |
| Aug 2026 | −$9.87 | −$6.40 | +35.2% |
| May 2026 | −$13.60 | −$0.20 | +98.5% |
| Mar 2026 | −$16.00 | −$0.21 | +98.7% |
| Nov 2025 | −$15.20 | −$16.80 | −10.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Feb 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.00 | — | — | $31.2M | — | — | — |
| Sep 2027 | −$4.15 | — | — | $7.9M | — | — | — |
| Jun 2027 | −$4.66 | — | — | $725.0K | — | — | — |
| Mar 2027 | −$0.07 | — | — | $725.0K | — | — | — |
| Dec 2026 | −$3.69 | — | — | $3.0M | — | — | — |
| Nov 4, 2026 | −$3.89 | — | — | $10.7M | — | — | — |
| Aug 13, 2026 | −$9.87 | −$6.40 | +35.2% | $3.6M | $9.2M | +154.6% | −9.4% |
| May 18, 2026 | −$13.60 | −$0.20 | +98.5% | $4.7M | $17.0M | +263.2% | −43.3% |
| Mar 18, 2026 | −$16.00 | −$0.21 | +98.7% | $7.5M | $13.8M | +83.4% | −8.0% |
| Nov 6, 2025 | −$15.20 | −$16.80 | −10.5% | $6.4M | $13.3M | +108.3% | +2.2% |
| Aug 11, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 14, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 15, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 17, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 24, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 22, 2019 | |||||||
| Feb 12, 2019 |